Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2020 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
ABL001, a Bispecific Antibody Targeting VEGF and DLL4, with Chemotherapy, Synergistically Inhibits Tumor Progression in Xenograft Models.
Int J Mol Sci. 2020 Dec 29;22(1):241. doi: 10.3390/ijms22010241.
Int J Mol Sci. 2020.
PMID: 33383646
Free PMC article.
Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer.
Kim DH, Lee S, Kang HG, Park HW, Lee HW, Kim D, Yoem DH, Ahn JH, Ha E, You WK, Lee SH, Kim SJ, Chun KH.
Kim DH, et al. Among authors: ha e.
BMB Rep. 2020 Nov;53(10):533-538. doi: 10.5483/BMBRep.2020.53.10.103.
BMB Rep. 2020.
PMID: 32580836
Free PMC article.
Item in Clipboard
Hepatitis C virus NS5A protein increases hepatic lipid accumulation via induction of activation and expression of PPARgamma.
Kim K, Kim KH, Ha E, Park JY, Sakamoto N, Cheong J.
Kim K, et al. Among authors: ha e.
FEBS Lett. 2009 Sep 3;583(17):2720-6. doi: 10.1016/j.febslet.2009.07.034. Epub 2009 Jul 23.
FEBS Lett. 2009.
PMID: 19631645
Free article.
Item in Clipboard
Cite
Cite